According to AstraZeneca's latest financial reports the company's current revenue (TTM ) is NZ$103.48 Billion. In 2025 the company made a revenue of NZ$101.42 Billion an increase over the revenue in the year 2024 that were of NZ$95.87 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.